// App-Quantinova.ai

BSH2020‐PO‐167 : Prospective cohort study of haemostatic activation markers and correlation with bleeding and thrombotic complications in patients receiving Veno‐Venous Extra‐Corporeal Membrane Oxygenation (VV‐ECMO) ‐HAE study

Researchers

Presenter

  • D. Jayakody Arachchillage

Principal Investigators

  • M. Gaspar

  • J. Ahnstroem

  • S. Fox

  • W. Banya

  • M. Passariello

  • S. Ledot

  • M. Laffan

Medical Centers

  • Department of Haematology, Imperial College Healthcare NHS Trust & Imperial College London

  • Department of Haematology, Royal Brompton Hospital

  • Department of Haematology, Imperial College London,

  • Department of Biostatistics

  • Adult Intensive Care Unit, Royal Brompton Hospital, London, UK

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Pulmonary/Respiratory Diseases

  • Cardiovascular (CVS)

  • Blood/haematological Diseases

Disease

  • Venous thrombosis

Biomarkers

  • D-dimer

  • von Willebrand factor

  • Activated partial thromboplastin time

Drug/Treatment

  • Heparin

  • folitixorin calcium

  • Evithrom

  • Heparin

  • Trypsin

Outcome

  • N/A

Study Design

  • Prospective

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved